The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRenold Regulatory News (RNO)

Share Price Information for Renold (RNO)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 56.60
Bid: 56.60
Ask: 56.80
Change: 0.60 (1.07%)
Spread: 0.20 (0.353%)
Open: 56.00
High: 57.40
Low: 56.00
Prev. Close: 56.00
RNO Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Publication of Prospectus

18 Nov 2009 17:40

RNS Number : 7345C
Renold PLC
18 November 2009
 



NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATESAUSTRALIACANADAJAPAN OR THE REPUBLIC OF SOUTH AFRICA OR ANY OTHER JURISDICTION IN WHICH THE SAME WOULD BE UNLAWFUL

Renold plc ("Renold" or "the Company")

Publication of Prospectus

Further to Renold's announcement yesterday in relation to a share issue to raise gross proceeds of approximately £28.5 million (approximately £26.9 million net of expenses) through the issue of 142,500,000 New Ordinary Shares by way of a Placing and Open Offer and Firm Placing at a price of 20 pence per New Ordinary Share, the Company announces that a prospectus relating to the Placing and Open Offer and Firm Placing (the "Prospectus") was approved by the UK Listing Authority (the "UKLA") yesterday. 

The Prospectus was posted to Shareholders yesterday and copies of the Prospectus, which includes a notice convening a general meeting of the Company to be held at Singer Capital Markets Limited, One Hanover Street, London W1S 1YX at 12.00 p.m. on 9 December 2009, have been made available for inspection at the UKLA's Document Viewing Facility, which is situated at Financial Services Authority, 25 The North Colonnade, Canary Wharf, London E14 5HS. 

In addition, the Prospectus is available to view on the Company's website (www.renold.com). Copies of the Prospectus will be available from the registered office of Renold at Renold House, Styal Road, Wythenshawe, Manchester M22 5WL and will be available for inspection up to Admission at the offices of Eversheds LLP at 1 Wood Street, London EC2V 7WS and Singer Capital Markets Limited at One Hanover Street, London W1S 1YX

Capitalised terms in this announcement have the same meaning as in Renold's announcement released yesterday

For further information, please contact: 

Renold plc 0161 498 4500 

Hannah Woodcock 

Singer Capital Markets, which is a member of the London Stock Exchange and is authorised and regulated in the United Kingdom by the FSA, is acting exclusively for the Company and no one else in connection with the Placing and Open Offer and Firm Placing and Admission. It will not be responsible to anyone other than the Company for providing the protections afforded to customers of Singer Capital Markets or for advising any other person on the transactions and arrangements referred to herein. No representation or warranty, express or implied, is made by Singer Capital Markets as to any of the contents of this announcement for which the Company and the Directors are solely responsible. Singer Capital Markets has not authorised the contents of, or any part of, this announcement and (without limiting the statutory rights of any person to whom this announcement is issued) no liability whatsoever is accepted by Singer Capital Markets for the accuracy of any information or opinions contained in this announcement or for the omission of any material information, for which the Company and the Directors are solely responsible.

Smith & Williamson, which is a member of the London Stock Exchange and is authorised and regulated in the United Kingdom by the FSA, is acting exclusively for the Company and no one else in connection with the Placing and Open Offer and Firm Placing and Admission. It will not be responsible to anyone other than the Company for providing the protections afforded to customers of Smith & Williamson or for advising any other person on the transactions and arrangements referred to herein. No representation or warranty, express or implied, is made by Smith & Williamson as to any of the contents of this announcement for which the Company and the Directors are solely responsible. Smith & Williamson has not authorised the contents of, or any part of, this announcement and (without limiting the statutory rights of any person to whom this announcement is issued) no liability whatsoever is accepted by Smith & Williamson for the accuracy of any information or opinions contained in this announcement or for the omission of any material information, for which the Company and the Directors are solely responsible.

This Announcement has been issued by and is the sole responsibility of the Company. No representation or warranty, express or implied is, or will be made as to, or in relation to, and no responsibility or liability is, or will be, accepted by either Singer Capital Markets or Smith & Williamson or by any of their affiliates or agents as to, or in relation to, the accuracy or completeness of this Announcement or any other written or oral information made available to or publicly available to any interested party or its advisers, and any liability therefore is expressly disclaimed.

THIS ANNOUNCEMENT IS AN ADVERTISEMENT. IT IS NOT A PROSPECTUS AND INVESTORS SHOULD NOT SUBSCRIBE FOR OR PURCHASE ANY SHARES REFERRED TO IN THIS ANNOUNCEMENT EXCEPT ON THE BASIS OF INFORMATION CONTAINED IN THE PROSPECTUS. 

Neither the content of Renold's website nor any website accessible by hyperlinks on Renold's website is incorporated in, or forms part of, this Announcement.

This Announcement is not for release, publication or distribution, directly or indirectly, in or into the United StatesAustraliaCanadaJapan or South Africa or any other jurisdiction into which the same would be unlawful. 

 

This Announcement does not contain or constitute an offer of, or the solicitation of an offer to buy or subscribe for, the New Ordinary Shares or any other securities to any person in Australia, Canada, Japan or South Africa, or the United States or in any jurisdiction to whom or in which such offer or solicitation is unlawful. Subject to certain exceptions, the securities referred to herein may not be offered or sold in AustraliaCanadaJapan or South Africa or to, or for the account or benefit of, any national, resident or citizen of AustraliaCanadaJapan or South Africa. The offer and sale of the securities referred to herein has not been and will not be registered under the US Securities Act or under the applicable securities laws of AustraliaCanadaJapan or South Africa. The availability of the Placing and Open Offer and Firm Placing to persons not resident in the United Kingdom may be affected by the laws of the relevant jurisdictions. Such persons should inform themselves about and observe any application requirements. 

 

The New Ordinary Shares have not been and will not be registered under the US Securities Act or under the securities laws of any state or other jurisdiction of the United States or under any securities laws of Australia, Canada, Japan or South Africa or any other jurisdiction where to do so would be unlawful and may not be offered, sold, taken up, exercised, resold, renounced, transferred or delivered, directly or indirectly, within the United States, or within any of Australia, Canada, Japan or South Africa or any other jurisdiction where to do so would be unlawful. There will be no public offer of the New Ordinary Shares in the United States

 

The distribution of this Announcement and the offering of the New Ordinary Shares in jurisdictions other than the United Kingdom may be restricted by law. No action has been taken by the Company, Singer Capital Markets or Smith & Williamson that would permit an offering of such shares or possession or distribution of this Announcement or any other offering or publicity material relating to such shares in any jurisdiction where action for that purpose is required. Persons into whose possession this Announcement comes are required by the Company, Singer Capital Markets and Smith & Williamson to inform themselves about, and to observe, any such restrictions. Any failure to comply with these restrictions may constitute a violation of the securities laws of any such jurisdiction.

This Announcement is for information only and does not constitute or form part of any offer or invitation to issue, acquire or dispose of any securities or investment advice in any jurisdiction. 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
PDIDVLFFKFBXFBD
Date   Source Headline
12th Oct 20177:00 amRNSTrading Update
4th Oct 20173:11 pmRNSHolding(s) in Company
10th Aug 20175:16 pmRNSDirector Declaration
1st Aug 201711:37 amRNSBlock listing Interim Review
19th Jul 201712:29 pmRNSResult of AGM
19th Jul 20177:00 amRNSAGM Statement
14th Jul 201711:14 amRNSHolding(s) in Company
16th Jun 20177:00 amRNSAnnual Report and Accounts
7th Jun 20172:26 pmRNSGrant of Awards - Performance Share Plan
2nd Jun 20174:40 pmRNSHolding(s) in Company
30th May 20177:00 amRNSFinal Results
4th May 201711:00 amRNSHolding(s) in Company
28th Apr 201710:39 amRNSHolding(s) in Company
27th Apr 20177:00 amRNSNotification of Investor Visit
18th Apr 20171:21 pmRNSHolding(s) in Company
13th Apr 201710:35 amRNSHolding(s) in Company
11th Apr 20177:00 amRNSTrading Update
2nd Feb 20173:32 pmRNSBlock listing Interim Review
19th Jan 20173:08 pmRNSGrant of Awards - Performance Share Plan
9th Jan 20177:00 amRNSAppointment of Non-Executive Director
22nd Dec 20167:00 amRNSStrategic Update
23rd Nov 20161:48 pmRNSHolding(s) in Company
15th Nov 20167:00 amRNSHalf-year Report
13th Oct 201612:02 pmRNSPrice Monitoring Extension
13th Oct 20167:00 amRNSTrading Update
11th Oct 201612:07 pmRNSSecond Price Monitoring Extn
11th Oct 201612:02 pmRNSPrice Monitoring Extension
4th Oct 20162:28 pmRNSHolding(s) in Company
28th Sep 20167:45 amRNSHolding(s) in Company
16th Sep 20164:35 pmRNSPrice Monitoring Extension
6th Sep 20167:00 amRNSAppointment of new Finance Director
1st Sep 20167:00 amRNSUpdate on Strategic Plan
1st Aug 201611:31 amRNSBlock listing Interim Review
22nd Jul 20162:59 pmRNSEmployee Benefit Trust
21st Jul 20163:07 pmRNSGrant of Awards - Performance Share Plan
20th Jul 201611:33 amRNSResult of AGM
20th Jul 20167:01 amRNSDirectorate Change
20th Jul 20167:00 amRNSAGM Statement
17th Jun 20167:00 amRNSNotice of AGM
31st May 20167:00 amRNSRenold FY Results YE 31 March 2016
14th Apr 20169:00 amRNSNotice of Results
14th Apr 20167:00 amRNSTrading Update
12th Apr 20169:38 amRNSHolding(s) in Company
16th Feb 20169:08 amRNSHolding(s) in Company
12th Feb 201610:44 amRNSDirector/PDMR Shareholding
12th Feb 201610:21 amRNSHolding(s) in Company
12th Feb 201610:21 amRNSHolding(s) in Company
12th Feb 20169:42 amRNSHolding(s) in Company
11th Feb 201612:53 pmRNSDirector/PDMR Shareholding
11th Feb 20169:28 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.